Sea4Us was recently featured in Portugal Startup News in an article dedicated to our mission, our marine-inspired drug discovery platform, and the potential of Sea4Pain in the development of new solutions for chronic pain.

Under the title “Sea4Us 101: How their marine-inspired Sea4Pain drug offers hope for chronic pain patients”, the article offers a clear and accessible overview of Sea4Us’ journey: from the marine biodiversity of the Sagres coast, which inspires our research, to the identification of compounds with therapeutic potential capable of modulating ion channels – key targets in several diseases with high unmet medical needs.

The focus on Sea4Pain, our most advanced therapeutic programme, reinforces the importance of continuing to develop non-opioid and non-addictive alternatives for chronic pain, a condition that affects millions of people worldwide and continues to have a profound impact on patients’ quality of life, families, healthcare systems, and society.

More than a story about innovation, this article reflects what has driven Sea4Us from the beginning: transforming knowledge from the ocean into innovative, safe, and clinically relevant medicines. Our approach combines marine biology, neuroscience, electrophysiology, and pharmaceutical development to create new therapeutic solutions with real impact.

We thank Portugal Startup News and Elham P. Mohammadi for their interest, thorough research, and clear communication of complex topics such as marine drug discovery, ion channels, chronic pain, and biotechnology innovation.

From the depths of the ocean to the laboratory – and from the laboratory to patients – we remain committed to building a future with better therapeutic options for people living with chronic pain.